ProfessionalsJonathan H. Ashtor
Jonathan Ashtor is a partner in the Corporate Department and a member of the Intellectual Property Group. His practice focuses on technology M&A transactions, IP licensing, patent analytics and portfolio monetization. His experience has included major, complex and multi-jurisdictional M&A across a variety of industry sectors, including high-tech, biopharma, industrial chemicals and manufacturing.
Mr. Ashtor’s expertise also includes complex analytics of patent matters through the use of proprietary models and commercial databases, and he develops new analytics tools through his academic research appointments. His work in this area has won significant awards and been published in peer-reviewed empirical and legal journals. Jonathan is also a Professor of Practice at the Benjamin N. Cardozo School of Law.
Mr. Ashtor’s practice covers several areas including:
- technology M&A, including public company mergers, private equity transactions, venture-backed IPOs and acquisitions, spinoffs and joint ventures;
- technology development and collaboration agreements, global distribution and commercialization agreements and technology financing;
- patent and other intellectual property licenses, software and IT agreements, logistics and operations services agreements and data licensing arrangements; and
- patent analytics involving a variety of technologies, including mobile communications, pharma and biochem, nanotech, AI, AR/VR and green tech.
Some recent transactions include:
- International Business Machines Corp. in its $34 billion acquisition of Red Hat Inc., creating the world’s largest hybrid cloud provider.
- General Electric in the $21.4 billion sale of its BioPharma business to Danaher Corporation.
- Teladoc Health, a New York-based telemedicine and virtual healthcare company, in its proposed $18.5 billion acquisition of Livongo Health, Inc., a California-based Applied Health Signals company.
- Elanco Animal Health Incorporated, an Indiana-based animal health company that develops products and knowledge services to prevent and treat disease in food, animals and pets, in its $7.6 billion carve-out acquisition of the animal health business of Bayer AG, a German-based enterprise with core competencies in the life science fields of health care and nutrition. The transaction involved advising on and negotiating several business-critical and complex licensing and R&D arrangements with respect to patents and other core technology assets, including to address the animal health business's competitive advantage, freedom to operate and key pipeline assets.
- Aptiv plc, an Ireland-based auto parts company, in its $4 billion autonomous driving joint venture with Hyundai Motor Group, a South Korea-based automotive manufacturer.
- Nuance Communications, Inc., a Massachusetts-based conversational AI innovator, in its:
- spin-off of its automotive software business; and
- $400 million sale of its Document Imaging division to Kofax, Inc., a California-based supplier of software and solutions for human and information intensive processes.
- Alexion Pharmaceuticals, a Massachusetts-based biopharmaceutical company focused on serving patients affected by rare and devastating diseases, in its $1.4 billion acquisition of Portola Pharmaceuticals Inc., a California-based commercial-stage biopharmaceutical company focused on life-threatening blood-related disorders.
- Trane Technologies in the $15 billion Reverse Morris Trust spinoff and merger of its industrial business with Gardner Denver Holdings, a provider of industrial equipment and technologies, creating a $15 billion global leader in mission-critical flow and industrial technologies.
- Signature Bank in the development of its new blockchain-based digital payments platform, Signet. The platform, designed to enable real-time payments for its commercial clients, is a partnership between Signature and trueDigital Holdings, LLC, a New York-based exchange and settlement technology company.
- Ericsson in the divestment of a 51% ownership stake in its Media Solutions business to One Equity Partners, a New York-based private equity firm. The Media Solutions business offers a wide-ranging media portfolio, including hardware and software video compression solutions, and serves a broad base of operators, service providers, broadcasters, content providers and aggregators. The transaction structure is intended to further develop the Media Solutions business and establish it as a leading independent video technology company. The transaction involved advising on several technology licensing matters.
- Qualcomm Incorporated, a California-based provider of 3G, 4G and next-generation wireless technologies, in its proposed acquisition of NXP Semiconductors N.V. for approximately $47 billion.
- Honeywell, a Fortune 100 software-industrial company, in its spin-off of Garrett Motion Inc., Honeywell’s former Transportation Systems business.
- Virtu Financial, Inc., a New York-based technology-enabled market maker, in its approximately $1 billion acquisition of Investment Technology Group, Inc., a New York-based financial technology company.
- Virtu Financial, Inc., a New York-based technology-enabled market maker, in its approximately $1.4 billion acquisition of KCG Holdings, Inc., a New Jersey-based independent securities firm, and in the related $750 million investment in Virtu by North Island, GIC, Public Sector Pension Investment Board and Temasek.
- Mitsubishi Chemical America in its acquisition of Gelest, Inc., a Pennsylvania-based innovator, manufacturer, and supplier of silicones, organosilanes, metal-organics and specialty monomers for advanced technology end markets, from New Mountain Capital LLC.
- MagnaChip Semiconductor Corporation, a designer and manufacturer of analog and mixed-signal semiconductor platform solutions, in the sale, valued at approximately $435 million, of its Foundry Services Group and fabrication plant in Cheongju, Korea by certain of MagnaChip’s wholly-owned subsidiaries to a special purpose company established by Alchemist Capital Partners Korea Co., Ltd. and Credian Partners, Inc.
- HP Inc. in its $1.05 billion acquisition of the global printer business of Samsung Electronics Co., Ltd., including negotiating ancillary intellectual property-related agreements and structuring certain aspects of the separation of the business.
- Endeavor Streaming, a provider of over-the-top streaming services and a division of Endeavor, a global leader in entertainment, media and sports, in connection with the negotiation and drafting of key technology services agreements with WWE for the operation and support of its WWE Network streaming platform.
- Farelogix, a Florida-based airline commerce and distribution technology company, in its sale to Accelya, a Spain-based provider of airline revenue management and logistics technology and a portfolio company of Vista Equity Partners.
- SoftBank Vision Fund, alongside various global investors, in the US$1.9 billion investment in Full Truck Alliance, a China-based truck-hailing company.
- Advance, a New York-based company that operates and invests in media, communications and technology businesses, in its acquisition of Palladian Holdings, Inc., owner of Turnitin, a California-based provider of plagiarism detection technology and other related products from an investment entity affiliated with Insight Venture Partners, GIC and their co-investors.
- Mitel Networks Corporation, a Canada-based business communications provider, in its $530 million acquisition of ShoreTel, a California-based communication solutions provider, involving the acquisition of a significant international IP portfolio, as well as advising on IP issues relating to outbound affiliate licenses and historical IP disputes; and in Mitel’s approximately $2 billion acquisition by an investor group led by affiliates of Searchlight Capital Partners, L.P.
- KPS Capital Partners in the sale of Genesis Attachments, LLC to NPK Construction Equipment, Inc.
- International Business Machines Corp. in the pending acquisition of assets of IBM’s sales performance management business by Great Hill Partners and Spectrum Equity to form Varicent Software, a Canada-based performance management company.
- The Medicines Company, a New Jersey-based biopharmaceutical company, in its offering of $150 million of common stock, lead managed by Goldman Sachs and J.P. Morgan.
- Representation of certain private equity and hedge fund clients in connection with technology M&A and licensing transactions, including IT and data rights arrangements.
Mr. Ashtor has also published numerous empirical studies focusing on patents and innovation economics. He regularly presents at research and practitioner conferences worldwide.
Awards and Fellowships
Leonardo Da Vinci Research Fellowship (2017)
Financial Times North America “Innovative Lawyers” Rankings (2015)
Thomas Edison Innovation Fellowship (2015)
Samsung-Stanford Patent Prize (2011)